New Zealand markets close in 3 hours 56 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6400-0.0700 (-2.58%)
At close: 04:00PM EDT
2.6400 0.00 (0.00%)
After hours: 04:03PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.7100
Open2.7100
Bid2.6200 x 900
Ask2.6500 x 600
Day's range2.5100 - 2.7400
52-week range0.5000 - 3.2200
Volume2,308,607
Avg. volume2,607,922
Market cap396.869M
Beta (5Y monthly)1.71
PE ratio (TTM)N/A
EPS (TTM)-0.8000
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.00
  • PR Newswire

    Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

    Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it will host an Investor Day on Wednesday, May 15, 2024 in New York City, beginning at 9:30 am ET. The event will include presentations from members of the Company's leadership team highlighting the renewed focus across the Acute Care and Oncology franchises and panel discussions featuring patient and physician experience with Heron's commercial products. The presentations will also include up

  • PR Newswire

    Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

    Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Wednesday, April 10, 2024, at 11:00 AM ET at the 23rd Annual Needham Virtual Healthcare Conference. The conference is being held in a virtual format, April 8-11, 2024.

  • Simply Wall St.

    Heron Therapeutics Full Year 2023 Earnings: Beats Expectations

    Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...